Skip to content

Clinical trials

Phase 2 Gallbladder Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gallbladder Neoplasms Phase: Phase 2 Country / region: China Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20121
20163
20171
20181
20191
20204
20211
20222
20231
20244
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status9
Recruiting6
Completed5
Enrolling by invitation3
Not yet recruiting1
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shanghai Jiao Tong University School of Medicine4
Tianjin Medical University Cancer Institute and Hospital3
Eastern Hepatobiliary Surgery Hospital2
ASLAN Pharmaceuticals1
Bayer1
CSPC Ouyi Pharmaceutical Co., Ltd.1
Cancer Institute and Hospital, Chinese Academy of Medical Sciences1
EMD Serono Research & Development Institute, Inc.1
First Affiliated Hospital of Zhejiang University1
GV20 Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gallbladder Neoplasms26
Cholangiocarcinoma12
Biliary Tract Neoplasms7
Bile Duct Neoplasms3
Colorectal Neoplasms2
Klatskin Tumor2
Pancreatic Neoplasms2
Uterine Cervical Neoplasms2
Breast Neoplasms1
Camurati-Engelmann Syndrome1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.